Novartis boasts strong new drug sales, streamlined marketing spend in Q2 earnings
July 19 2012
Novartis continued to shrink its marketing spend in the second quarter, and Excedrin woes will continue until the fourth quarter, ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.